Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Candida albicans morphogenesis pathway refers to the complex network of molecular and cellular processes that enable this fungal pathogen to switch between different morphological forms, primarily yeast and hyphal states. This dimorphic transition is central to the organism’s virulence, tissue invasion, immune evasion, and biofilm formation. Key signaling pathways include cAMP-PKA, MAPK/Cph1, Rim101, and TOR kinase, which are regulated by environmental cues and transcription factors such as Efg1, Cph1, and Nrg1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Candida albicans Morphogenesis Pathway.